Tranexamic acid 500 (Tranexamic acid Tablet) 500mg

Tranexamic acid 500 is an antifibrinolytic agent used to manage conditions involving excessive bleeding. It is particularly effective in the following indications:

• Heavy menstrual bleeding (menorrhagia): Reduces the amount of blood loss during menstruation.
• Trauma-related bleeding: Helps control bleeding in trauma patients.
• Surgical bleeding: Used to minimize blood loss during and after surgical procedures.
• Hereditary angioedema prophylaxis: Prevents bleeding episodes in patients with hereditary angioedema.
• Nosebleeds (epistaxis): Reduces the severity and duration of nosebleeds.

• Tranexamic acid works by inhibiting the conversion of plasminogen to plasmin, a key enzyme in the breakdown of blood clots. By binding to plasminogen, it prevents the dissolution of fibrin, thereby stabilizing clots and reducing bleeding. This mechanism makes it effective in managing conditions where excessive fibrinolysis occurs.

Tranexamic acid 500 may cause various side effects, ranging from common to serious. Common Side Effects:

• Headache: A frequent side effect reported by users.
• Nausea: Some patients may experience nausea.
• Dizziness: A common complaint among users.
• Diarrhea: May occur in some individuals.
• Fatigue: Some users report feeling tired.
• Visual disturbances: Impaired color vision and other visual disturbances have been reported.

Serious or Rare Side Effects

• Thromboembolism: Increased risk of blood clots, including deep vein thrombosis and pulmonary embolism.
• Allergic reactions: Severe allergic reactions, including anaphylactic shock, have been reported.
• Cerebral edema: Rare but serious side effect in patients with subarachnoid hemorrhage.
• Ligneous conjunctivitis: A rare condition characterized by thick, woody-like growths on the conjunctiva.

Tranexamic acid 500 should be used with caution and under medical supervision. Important precautions include:

• Thromboembolic risk: Avoid use in patients with a history of thrombosis or thromboembolism.
• Renal impairment: Dosage adjustment is necessary for patients with impaired renal function.
• Combined hormonal contraceptives: Concomitant use is contraindicated due to increased risk of thromboembolism.
• Hypersensitivity: Avoid use in patients with known hypersensitivity to tranexamic acid.
• Pregnancy: Use with caution during pregnancy, as safety data are limited.
• Store below 25°C: Keep in the original pack, protect from moisture.

Tranexamic acid 500 may interact with other medications, potentially affecting its efficacy or increasing the risk of side effects. Major Interactions (Avoid):

• Combined hormonal contraceptives: Increases the risk of thromboembolism.
• Factor IX complex concentrates: May increase the risk of thrombosis.
• Anti-inhibitor coagulant concentrates: May increase the risk of thrombosis.
• All-trans retinoic acid (oral tretinoin): May increase the risk of thrombosis.

Moderate Interactions (Monitor Closely)

• Tissue plasminogen activators: May decrease the efficacy of both tranexamic acid and tissue plasminogen activators.
• Other antifibrinolytic agents: May increase the risk of side effects.
• Medications that increase the risk of thromboembolism: May require close monitoring.